Bank of Nova Scotia’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $143M | Buy |
5,108,792
+1,865,170
| +58% | +$49.7M | 0.25% | 73 |
|
|
2025
Q4 | $80.8M | Buy |
3,243,622
+389,592
| +14% | +$9.82M | 0.12% | 138 |
|
|
2025
Q3 | $72.7M | Buy |
2,854,030
+545,012
| +24% | +$13.5M | 0.13% | 131 |
|
|
2025
Q2 | $56M | Sell |
2,309,018
-799,953
| -26% | -$18.7M | 0.11% | 143 |
|
|
2025
Q1 | $78.8M | Sell |
3,108,971
-1,204,668
| -28% | -$31.5M | 0.18% | 102 |
|
|
2024
Q4 | $114M | Buy |
4,313,639
+984,840
| +30% | +$26.7M | 0.2% | 84 |
|
|
2024
Q3 | $96.3M | Sell |
3,328,799
-2,551,084
| -43% | -$74.4M | 0.19% | 86 |
|
|
2024
Q2 | $165M | Buy |
5,879,883
+63,789
| +1% | +$1.76M | 0.32% | 52 |
|
|
2024
Q1 | $161M | Sell |
5,816,094
-2,024,098
| -26% | -$56.2M | 0.33% | 53 |
|
|
2023
Q4 | $226M | Buy |
7,840,192
+2,336,209
| +42% | +$70.6M | 0.42% | 44 |
|
|
2023
Q3 | $183M | Buy |
5,503,983
+3,780,696
| +219% | +$134M | 0.48% | 38 |
|
|
2023
Q2 | $63.2M | Sell |
1,723,287
-106,900
| -6% | -$4.16M | 0.17% | 106 |
|
|
2023
Q1 | $74.7M | Sell |
1,830,187
-740,956
| -29% | -$32M | 0.22% | 77 |
|
|
2022
Q4 | $132M | Buy |
2,571,143
+707,047
| +38% | +$33.9M | 0.34% | 60 |
|
|
2022
Q3 | $81.6M | Sell |
1,864,096
-1,244,596
| -40% | -$60.5M | 0.26% | 70 |
|
|
2022
Q2 | $163M | Sell |
3,108,692
-774,514
| -20% | -$39.5M | 0.39% | 56 |
|
|
2022
Q1 | $201M | Sell |
3,883,206
-3,975,796
| -51% | -$206M | 0.34% | 63 |
|
|
2021
Q4 | $474M | Sell |
7,859,002
-30
| -0% | -$1.49K | 0.66% | 31 |
|
|
2021
Q3 | $334M | Buy |
7,859,032
+2,282,958
| +41% | +$101M | 0.59% | 33 |
|
|
2021
Q2 | $218M | Sell |
5,576,074
-2,240,507
| -29% | -$87.1M | 0.4% | 57 |
|
|
2021
Q1 | $283M | Buy |
7,816,581
+4,148,877
| +113% | +$147M | 0.56% | 39 |
|
|
2020
Q4 | $135M | Sell |
3,667,704
-3,002,457
| -45% | -$110M | 0.29% | 84 |
|
|
2020
Q3 | $232M | Buy |
6,670,161
+3,769,818
| +130% | +$132M | 0.63% | 30 |
|
|
2020
Q2 | $90M | Sell |
2,900,343
-2,421,370
| -45% | -$82.3M | 0.31% | 80 |
|
|
2020
Q1 | $165M | Sell |
5,321,713
-591,782
| -10% | -$20.2M | 0.57% | 40 |
|
|
2019
Q4 | $220M | Buy |
5,913,495
+1,523,284
| +35% | +$54.3M | 0.53% | 47 |
|
|
2019
Q3 | $150M | Buy |
4,390,211
+1,954,614
| +80% | +$71.1M | 0.44% | 55 |
|
|
2019
Q2 | $99.2M | Sell |
2,435,597
-42,335
| -2% | -$1.68M | 0.42% | 56 |
|
|
2019
Q1 | $99.8M | Sell |
2,477,932
-657,051
| -21% | -$26.3M | 0.4% | 59 |
|
|
2018
Q4 | $130M | Buy |
3,134,983
+467,074
| +18% | +$19.4M | 0.61% | 40 |
|
|
2018
Q3 | $112M | Buy |
2,667,909
+802,605
| +43% | +$30.9M | 0.5% | 47 |
|
|
2018
Q2 | $64.2M | Buy |
1,865,304
+660,173
| +55% | +$22.6M | 0.35% | 58 |
|
|
2018
Q1 | $40.6M | Sell |
1,205,131
-2,503,584
| -68% | -$86.1M | 0.21% | 99 |
|
|
2017
Q4 | $127M | Buy |
3,708,715
+2,387,170
| +181% | +$81.4M | 0.58% | 36 |
|
|
2017
Q3 | $44.7M | Sell |
1,321,545
-695,179
| -34% | -$22.3M | 0.26% | 92 |
|
|
2017
Q2 | $64.3M | Sell |
2,016,724
-22,254
| -1% | -$702K | 0.34% | 60 |
|
|
2017
Q1 | $66.2M | Buy |
2,038,978
+1,560,192
| +326% | +$49.2M | 0.28% | 77 |
|
|
2016
Q4 | $14.8M | Buy |
478,786
+302,989
| +172% | +$9.25M | 0.08% | 162 |
|
|
2016
Q3 | $5.66M | Buy |
175,797
+13,687
| +8% | +$458K | 0.03% | 208 |
|
|
2016
Q2 | $5.41M | Sell |
162,110
-25,676
| -14% | -$819K | 0.03% | 205 |
|
|
2016
Q1 | $5.28M | Buy |
187,786
+31,913
| +20% | +$912K | 0.03% | 216 |
|
|
2015
Q4 | $4.78M | Sell |
155,873
-7,866
| -5% | -$247K | 0.02% | 247 |
|
|
2015
Q3 | $4.88M | Buy |
163,739
+9,190
| +6% | +$295K | 0.03% | 194 |
|
|
2015
Q2 | $4.92M | Buy |
154,549
+10,404
| +7% | +$339K | 0.02% | 182 |
|
|
2015
Q1 | $4.76M | Sell |
144,145
-23,050
| -14% | -$733K | 0.02% | 181 |
|
|
2014
Q4 | $4.94M | Sell |
167,195
-3,792
| -2% | -$109K | 0.02% | 186 |
|
|
2014
Q3 | $4.8M | Sell |
170,987
-40,650
| -19% | -$1.14M | 0.02% | 188 |
|
|
2014
Q2 | $5.96M | Sell |
211,637
-1,077,413
| -84% | -$30.7M | 0.02% | 176 |
|
|
2014
Q1 | $39.3M | Buy |
1,289,050
+657,059
| +104% | +$19.6M | 0.16% | 76 |
|
|
2013
Q4 | $18.4M | Buy |
631,991
+244,378
| +63% | +$7.11M | 0.08% | 124 |
|
|
2013
Q3 | $10.6M | Sell |
387,613
-47,198
| -11% | -$1.28M | 0.05% | 126 |
|
|
2013
Q2 | $11.6M | Buy |
+434,811
| New | +$12M | 0.06% | 129 |
|
Other funds holding PFE
VCM
VPM
Bank of Nova Scotia's PFE Position: Q1 2026 in Review
Bank of Nova Scotia increased its Pfizer (PFE) stake by 58% in Q1 2026, buying an estimated $49.7M and bringing the position to 5,108,792 shares worth $143M. The position accounts for 0.25% of the portfolio, ranked #73.
Bank of Nova Scotia first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $474M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bank of Nova Scotia held 5,108,792 shares of Pfizer worth $143M as of Q1 2026.
- Bank of Nova Scotia bought 1,865,170 Pfizer shares in Q1 2026, an estimated $49.7M.
- Pfizer made up 0.25% of Bank of Nova Scotia's portfolio in Q1 2026, its #73 holding.
- Bank of Nova Scotia first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bank of Nova Scotia's Pfizer position peaked at $474M in Q4 2021.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.